Herceptin is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Genentech, Inc.. The primary component is Trastuzumab.
Product ID | 50242-132_23b49e45-e152-40c5-bbc9-be52fce667af |
NDC | 50242-132 |
Product Type | Human Prescription Drug |
Proprietary Name | Herceptin |
Generic Name | Trastuzumab |
Dosage Form | Injection, Powder, Lyophilized, For Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2017-02-10 |
Marketing Category | BLA / BLA |
Application Number | BLA103792 |
Labeler Name | Genentech, Inc. |
Substance Name | TRASTUZUMAB |
Active Ingredient Strength | 150 mg/7.4mL |
Pharm Classes | HER2/neu Receptor Antagonist [EPC],HER2/Neu/cerbB2 Antagonists [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2017-02-10 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA103792 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2019-06-03 |
Marketing Category | BLA |
Application Number | BLA103792 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2017-02-10 |
Ingredient | Strength |
---|---|
TRASTUZUMAB | 150 mg/7.4mL |
SPL SET ID: | 492dbdb2-077e-4064-bff3-372d6af0a7a2 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
50242-132 | Herceptin | Trastuzumab |
50242-134 | Herceptin | Trastuzumab |
50242-333 | Herceptin | Trastuzumab |
63459-303 | HERZUMA | TRASTUZUMAB |
63459-305 | HERZUMA | TRASTUZUMAB |
67457-845 | OGIVRI | trastuzumab |
67457-847 | OGIVRI | trastuzumab |
67457-991 | OGIVRI | trastuzumab |
0006-5033 | Ontruzant | trastuzumab |
0069-0305 | Trazimera-qyyp | trastuzumab |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
HERCEPTIN 74733146 2157198 Live/Registered |
GENENTECH, INC. 1995-09-22 |